FindTrial
Sign In

Role of saindhav lavana with shavasan in primary hypertension a randomized controlled trial

synergetic effect of saindhav lavana as a dietary adaptation along with shavasan for primary hypertension a randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/09/036914
Enrollment
60
Registered
2021-09-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Saindhav lavan with shavasan in primary hypertension: Group A of 30 patients having primary hypertension will treated by saindhav lavan with shavasan. Duration of shavasan procedure for

Sponsors

SHREE AYURVED MAHAVIDYALAYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. patient will be randomly selected for the study irrespective of their caste,gender,marital status and economic class 2. newly diagnosed patient of essential hypertension 3. systolic blood pressure 121-159 mmhg 4. diastolic blood pressure 81-99 mmhg 5. patient who can follow the given instruction and willing to give written consent to participate in the study

Exclusion criteria

Exclusion criteria: 1. Stage second hypertension 2. All the patient of secondary hypertension will be excluded such as, Endocrinal disorders Taking oral contraceptives Hypertension associated with DM Hypertension associated with pregnancy

Design outcomes

Primary

MeasureTime frame
Reduction in blood pressure by consuming saindhav lavana with practicing shavasanTimepoint: 2 months—

Secondary

MeasureTime frame
N/ATimepoint: N/A—

Countries

India

Contacts

Public ContactPriyanka Suresh undre

shri ayurved mahavidyalay nagpur

drsapnaukey@gmail.com9890242929

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026